Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A V Fonyakin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Kardiologiia|March 15, 2017
[Rivaroxaban at Non-Valvular Atrial Fibrillation: a Prospective Study and Clinical Practice]A V Fonyakin
Kardiologiia|February 1, 2021
[The new Epoch of Antithrombotic Therapy in the Long-Term Prevention of a non-Cardioembolic Stroke]A V Fonyakin, L A Geraskina
Kardiologiia|March 16, 2017
[Arterial Hypertension and Optimization of Medication Prevention of Ischemic Stroke]A V Fonyakin, L A Geraskina
Terapevticheskii Arkhiv|October 26, 2022
[Prevention of ischemic stroke in atrial fibrillation from the point of view of a neurologist. Standards and real clinical practice]M Y Maksimova, A V Fonyakin, L A Geraskina
Klinicheskaia Meditsina|March 19, 2016
[Prophylaxis of ischemic stroke]E A Shirokov, A V Fonyakin, L A Geraskina
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 17, 2017
[Sleep-disordered breathing syndrome in acute ischemic stroke]G M Lutohin, L A Geraskina, A V Fonyakin
Kardiologiia|March 16, 2017
[APPLICATION Rivaroxaban for Secondary Stroke Prevention in Clinical Practice. RESULTS OF RUSSIAN Prospective, Multicenter, Observational Study NEURO-XAR]A V Fonyakin On Behalf Of The Working Group Of Researchers
Kardiologiia|March 16, 2017
[Prognostic Factors of Cardiovascular Complications After Ischemic Stroke]V A Shandalin, A V Fonyakin, L A Geraskina, et al.
Kardiologiia|April 30, 2016
[Proignostic Factors of Cardiovascular Complications After Ischemic Stroke]V A Shandalin, A V Fonyakin, L A Geraskina, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 16, 2016
[Prognostic factors of recurrent acute cerebrovascular incidents in patients with ischemic stroke]V A Shandalin, A V Fonyakin, L A Geraskina, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Kardiologiia|March 15, 2017
[Rivaroxaban at Non-Valvular Atrial Fibrillation: a Prospective Study and Clinical Practice]A V Fonyakin
Kardiologiia|February 1, 2021
[The new Epoch of Antithrombotic Therapy in the Long-Term Prevention of a non-Cardioembolic Stroke]A V Fonyakin, L A Geraskina
Kardiologiia|March 16, 2017
[Arterial Hypertension and Optimization of Medication Prevention of Ischemic Stroke]A V Fonyakin, L A Geraskina
Terapevticheskii Arkhiv|October 26, 2022
[Prevention of ischemic stroke in atrial fibrillation from the point of view of a neurologist. Standards and real clinical practice]M Y Maksimova, A V Fonyakin, L A Geraskina
Klinicheskaia Meditsina|March 19, 2016
[Prophylaxis of ischemic stroke]E A Shirokov, A V Fonyakin, L A Geraskina
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 17, 2017
[Sleep-disordered breathing syndrome in acute ischemic stroke]G M Lutohin, L A Geraskina, A V Fonyakin
Kardiologiia|March 16, 2017
[APPLICATION Rivaroxaban for Secondary Stroke Prevention in Clinical Practice. RESULTS OF RUSSIAN Prospective, Multicenter, Observational Study NEURO-XAR]A V Fonyakin On Behalf Of The Working Group Of Researchers
Kardiologiia|March 16, 2017
[Prognostic Factors of Cardiovascular Complications After Ischemic Stroke]V A Shandalin, A V Fonyakin, L A Geraskina, et al.
Kardiologiia|April 30, 2016
[Proignostic Factors of Cardiovascular Complications After Ischemic Stroke]V A Shandalin, A V Fonyakin, L A Geraskina, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 16, 2016
[Prognostic factors of recurrent acute cerebrovascular incidents in patients with ischemic stroke]V A Shandalin, A V Fonyakin, L A Geraskina, et al.
Pageof 2